CDH2 and cancer: Cancerous cells undergoing the EMT display a series of morphological features when acquiring the mesenchymal phenotype characterized by the increased expression of certain markers mostly associated with cell–cell adhesions such as N-cadherin, O-Cadherin, integrins, fibronectin, vimentin, FSP1 and β-catenin.